Miller-Meeks Bill to Detect and Prevent Cancer Signed Into Law
WASHINGTON, D.C. — Today, legislation led by Dr. Mariannette Miller-Meeks (IA-01) that would help detect and prevent cancer was signed into law by President Trump as part of a historic spending package.
The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act establishes Medicare coverage for Multi-Cancer Early Detection (MCED) screening tests, ensuring seniors will soon have access to cutting-edge diagnostics that can identify multiple cancers from a single test.
“As a doctor, I’ve seen firsthand how early detection can change the trajectory of a patient’s life,” Said Miller-Meeks. “This legislation ensures seniors have access to cutting-edge screening technologies that can detect cancer earlier, improve outcomes, and reduce suffering for patients and their families. It’s a meaningful step forward in the fight against cancer and I'm so proud that it has now been signed into law by President Trump.”
More on the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act:
- Establishes Medicare coverage for FDA-approved multi-cancer early detection (MCED) screening tests beginning in 2028.
- Defines MCED tests as those that can detect multiple cancer types across different organ systems from a single specimen.
- Limits tests to one annually per beneficiary.
- Implements age-based eligibility limits that increase over time.
- Sets reimbursement rates through 2030 at parity with current multi-target stool DNA tests.
- Allows CMS to reduce costs in 2031 and beyond using the clinical laboratory payment system.
- Clarifies that coverage of these tests will not displace existing cancer screenings.
- Provides CMS funding to implement coverage and oversight effectively.
###